文献速递乳腺癌放疗放疗物理与技术

乳腺癌患者心脏病风险:患者个体因素与三维放疗计划心脏剂量的影响

Risk of Cardiac Disease in Patients With Breast Cancer: Impact of Patient-Specific Factors and Individual Heart Dose From Three-Dimensional Radiation Therapy Planning.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2021-01-06

该回顾性队列研究纳入1294例接受乳腺癌手术的女性,其中520例接受辅助放疗、774例未放疗(心脏剂量记为0 Gy),评估放疗是否增加亚洲女性心脏毒性风险。结果显示心脏平均剂量每增加1 Gy,乳腺癌治疗相关心脏病风险显著升高(校正HR 1.23),高血压史(HR 1.92)和糖尿病史(HR 2.51)为危险因素,规律体育锻炼(HR 0.17)为保护因素。

要点

  • 心脏平均剂量每增加1 Gy,乳腺癌治疗相关心脏病风险显著升高(校正HR 1.23)。
  • 高血压史(HR 1.92)和糖尿病史(HR 2.51)为心脏毒性危险因素。
  • 规律体育锻炼(HR 0.17)为保护因素,即使无危险因素者也应尽量降低心脏剂量。

核心结论

  • 乳腺癌患者心脏疾病存在放疗剂量效应关系,即使采用三维放疗计划仍存在不可忽视的心脏毒性风险。
  • 建议对接受辅助放疗的乳腺癌患者常规实施最小化心脏剂量的措施,即使无任何心脏病危险因素者亦然。

研究设计与样本

  • 回顾性队列研究,纳入2005年1月至2013年5月接受原发性乳腺癌手术的女性,放疗组520例、未放疗组774例(心脏剂量记为0 Gy),共1294例。
  • 主要终点为乳腺癌治疗相关心脏病(BCT-HD),定义为心绞痛、不稳定型心绞痛、心肌梗死、缺血性心脏病、心力衰竭或心房颤动的诊断。

主要发现

  • 总体5年和10年BCT-HD发生率分别为2.4%和5.7%。
  • 心脏平均剂量每增加1 Gy,BCT-HD风险显著升高(校正HR 1.23)。
  • 高血压史(HR 1.92)和糖尿病史(HR 2.51)为不良危险因素,规律体育锻炼(HR 0.17)为保护因素。
  • 亚组分析显示,心脏平均剂量每增加1 Gy的效应在无或极少危险因素女性(HR 1.23)与多危险因素女性(HR 1.27)之间相似。

关键数值与推荐

  • BCT-HD定义包括心绞痛、不稳定型心绞痛、心肌梗死、缺血性心脏病、心力衰竭或心房颤动的诊断。
  • 心脏平均剂量每增加1 Gy的校正HR为1.23;高血压史HR 1.92;糖尿病史HR 2.51;规律体育锻炼HR 0.17。
  • 无或极少危险因素亚组每Gy的HR为1.23,多危险因素亚组为1.27。

临床怎么用

  • 在乳腺癌辅助放疗的三维计划中应常规评估并尽量降低心脏平均剂量,即使患者无心脏病危险因素。
  • 对合并高血压、糖尿病的乳腺癌放疗患者应加强心脏病风险监测与管理。
  • 可鼓励患者规律体育锻炼以降低心脏毒性风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This retrospective cohort study aimed to determine whether adjuvant radiation therapy increases the risk of cardiac toxicity in Asian women with breast cancer, with a focus on patient-specific factors. METHODS AND MATERIALS: We evaluated women who underwent primary breast surgery for breast cancer with (n = 520) or without (n = 774) adjuvant radiation therapy between January 2005 and May 2013. Patients who underwent breast surgery without radiation therapy were categorized as patients who received 0 Gy to the heart. The primary endpoint was the occurrence of a breast cancer treatment-related heart disease (BCT-HD), defined as a diagnosis of angina pectoris, unstable angina, myocardial infarction, ischemic heart disease, heart failure, or atrial fibrillation. RESULTS: In total, 1294 patients were included. The overall 5- and 10-year BCT-HD rates were 2.4% and 5.7%, respectively. The risk of an BCT-HD significantly increased per 1-Gy increase in the mean heart dose (adjusted hazard ratio: 1.23). Additionally, histories of hypertension (hazard ratio: 1.92), and diabetes (hazard ratio: 2.51) were found to be adverse risk factors, whereas regular physical exercise (hazard ratio: 0.17) was a protective factor. Subgroup analysis according to risk groups showed that the effect of increasing mean heart dose (per Gy) was similar between women without or with minimal risk factors (hazard ratio: 1.23) and women with multiple risk factors (hazard ratio: 1.27). CONCLUSIONS: The results indicate a radiation dose-effect relationship for cardiac disease in breast cancer patients, highlighting that there remains a considerable risk of cardiac toxicity even with 3-dimensional radiation therapy planning. Thus, measures to minimize the heart dose in breast cancer patients undergoing adjuvant radiation therapy, even in those without any risk factor for cardiac disease, should be routinely implemented.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Chung SY, Oh J, Chang JS, et al. Risk of Cardiac Disease in Patients With Breast Cancer: Impact of Patient-Specific Factors and Individual Heart Dose From Three-Dimensional Radiation Therapy Planning. Int J Radiat Oncol Biol Phys. 2021. PMID: 33421556. doi:10.1016/j.ijrobp.2020.12.053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。